Painreform Correlations

PRFX Stock

USD 3.02 0.23 7.08%

The correlation of Painreform is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Painreform Correlation With Market

Average diversification

The correlation between Painreform and DJI is 0.17 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Painreform and DJI in the same portfolio, assuming nothing else is changed.

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Painreform. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census.

For more information on how to buy Painreform Stock please use our How to Invest in Painreform guide.

Moving against Painreform Stock

0.44	ME	23Andme Holding	Pair Corr
0.44	DTIL	Precision BioSciences	Pair Corr
0.44	VIGL	Vigil Neuroscience	Pair Corr
0.42	DNLI	Denali Therapeutics	Pair Corr
0.38	VINC	Vincerx Pharma	Pair Corr
0.36	DNTH	Dianthus Therapeutics	Pair Corr
0.35	DRRX	Durect	Pair Corr
0.33	VALN	Valneva SE ADR	Pair Corr
0.31	DOMH	Dominari Holdings	Pair Corr
0.53	VRTX	Vertex Pharmaceuticals	Pair Corr
0.46	VTGN	VistaGen Therapeutics	Pair Corr
0.42	EDIT	Editas Medicine	Pair Corr
0.4	VRPX	Virpax Pharmaceuticals	Pair Corr
0.39	VKTX	Viking Therapeutics	Pair Corr
0.37	VRDN	Viridian Therapeutics Buyout Trend	Pair Corr
0.36	VXRT	Vaxart Inc	Pair Corr
0.34	VYGR	Voyager Therapeutics	Pair Corr
0.34	ELAN	Elanco Animal Health	Pair Corr
0.33	EDSA	Edesa Biotech	Pair Corr
0.31	VRCA	Verrica Pharmaceuticals	Pair Corr

Related Correlations Analysis

	QLI	RGC	PROC	JUPW	UPC	VRTHF	EGRX	SGBI	FLGC	CLVR
QLI		-0.23	-0.02	0.02	-0.84	0.0	-0.86	-0.63	-0.67	-0.29	QLI
RGC	-0.23		-0.41	-0.21	0.31	0.0	0.3	0.46	0.25	-0.15	RGC
PROC	-0.02	-0.41		-0.12	-0.2	0.0	0.07	-0.11	-0.07	-0.02	PROC
JUPW	0.02	-0.21	-0.12		0.25	0.0	-0.09	-0.52	-0.23	-0.01	JUPW
UPC	-0.84	0.31	-0.2	0.25		0.0	0.8	0.5	0.62	0.21	UPC
VRTHF	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	VRTHF
EGRX	-0.86	0.3	0.07	-0.09	0.8	0.0		0.55	0.7	0.25	EGRX
SGBI	-0.63	0.46	-0.11	-0.52	0.5	0.0	0.55		0.62	0.18	SGBI
FLGC	-0.67	0.25	-0.07	-0.23	0.62	0.0	0.7	0.62		0.4	FLGC
CLVR	-0.29	-0.15	-0.02	-0.01	0.21	0.0	0.25	0.18	0.4		CLVR
	QLI	RGC	PROC	JUPW	UPC	VRTHF	EGRX	SGBI	FLGC	CLVR

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

EGRX	+ 0.8	UPC
FLGC	+ 0.7	EGRX
FLGC	+ 0.62	UPC
FLGC	+ 0.62	SGBI
SGBI	+ 0.55	EGRX
SGBI	+ 0.5	UPC

High negative correlations

EGRX	- 0.86	QLI
UPC	- 0.84	QLI
FLGC	- 0.67	QLI
SGBI	- 0.63	QLI
SGBI	- 0.52	JUPW
PROC	- 0.41	RGC

Risk-Adjusted Indicators

There is a big difference between Painreform Stock performing well and Painreform Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Painreform's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
QLI	7.17	1.69	0.21	8.26	6.62	(10.37)	19.23	(12.37)	61.58
RGC	4.92	(0.15)	0.00	0.31	0.00	0.00	8.47	(10.93)	43.32
PROC	10.44	1.13	0.10	1.51	10.68	(15.48)	38.04	(18.67)	122.49
JUPW	4.58	0.39	0.07	0.25	4.91	(6.24)	8.57	(9.62)	61.38
UPC	10.53	(0.89)	0.00	1.20	0.00	0.00	9.52	(17.46)	282.15
VRTHF	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EGRX	3.94	(1.19)	0.00	2.87	0.00	0.00	9.24	(8.24)	53.71
SGBI	2.59	(1.35)	0.00	(0.87)	0.00	0.00	0.00	0.00	86.67
FLGC	5.61	(0.70)	0.00	(0.45)	0.00	0.00	10.83	(12.63)	50.27
CLVR	10,154	5,331	59.46	(1.79)	256.38	(58,095)	900.00	(99.20)	333,333

Painreform Corporate Management

Sigal Aviel	Chief Officer	Profile
Rita Keynan	Vice Operations	Profile
Eyal Broder	Interim Officer	Profile
MBA MBA	CEO CFO	Profile
Pr Hazum	CTO Director	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC